Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi

References

• J Mestres. (2005). Representativity of target families in the Protein Data Bank: Impact for family-directed structure-based drug discovery. Drug Discov Today 10:1629–1637.
   PubMed Web of Science ®Google Scholar
• JG Robertson. (2005). Mechanistic basis of enzyme-targeted drugs. Biochemistry 44:5561–5571.
   PubMed Web of Science ®Google Scholar
• O Lespinet. (2006). Labedan B. Orphan enzymes could be an unexplored reservoir of new drug targets. Drug Discov Today 11:300–305.
   PubMed Web of Science ®Google Scholar
• CT Supuran, and A Scozzafava. (2007). Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 15:4336–4350.
   PubMed Web of Science ®Google Scholar
• V Farutin, L Masterson, AD Andricopulo, J Cheng, R Riley, R Hakimi, J Frazer, and EH Cordes. (1999). Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase. J Med Chem 42:2422–2431.
   PubMed Web of Science ®Google Scholar
• AD Andricopulo, and CA Montanari. (2005). Structure-activity relationships for the design of small-molecule inhibitors. Mini Rev Med Chem 5:585–593.
   PubMed Web of Science ®Google Scholar
• C Beyrer, JC Villar, V Suwanvanichkij, S Singh, SD Baral, and EJ Mills. (2007). Neglected diseases, civil conflicts, and the right to health. Lancet 370:619–627.
   PubMed Web of Science ®Google Scholar
• MP Barrett, RJ Burchmore, A Stich, JO Lazzari, AC Frasch, JJ Cazzulo, and S Krishna. (2003). The trypanosomiases. Lancet 362:1469–1480.
   PubMed Web of Science ®Google Scholar
• S Nwaka, and A Hudson. (2006). Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5:941–955.
   PubMed Web of Science ®Google Scholar
• S Nwaka, and RG Ridley. (2003). Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov 2:919–928.
   PubMed Web of Science ®Google Scholar
• JH McKerrow, and JC Engel. (1999). Caffrey CR, Related Articles, Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg Med Chem 7:639–644.
   PubMed Web of Science ®Google Scholar
• PS Doyle, YM Zhou, JC Engel, and JH McKerrow. (2007). A Cysteine Protease Inhibitor Cures Chagas' Disease in an Immunodeficient Murine Model of Infection. Antimicrob Agents Chemother doi: 10.1128/AAC.00436-07
   Web of Science ®Google Scholar
• H Eckert, and J Bajorath. (2007). Molecular similarity analysis in virtual screening: Foundations, limitations and novel approaches. Drug Discov Today 12:225–233.
   PubMed Web of Science ®Google Scholar
• G Klebe. (2006). Virtual ligand screening: Strategies, perspectives and limitations. Drug Discov Today 11:580–594.
   PubMed Web of Science ®Google Scholar
• DB Kitchen, H Decornez, JR Furr, and J Bajorath. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov 3:935–949.
   PubMed Web of Science ®Google Scholar
• X Du, C Guo, E Hansell, PS Doyle, CR Caffrey, TP Holler, JH McKerrow, and FE Cohen. (2002). Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem 45:2695–2707.
   PubMed Web of Science ®Google Scholar
• KM Honorio, RC Garratt, and AD Andricopulo. (2005). Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators. Bioorg Med Chem Lett 15:3119–3125.
   PubMed Web of Science ®Google Scholar
• KM Honorio, RC Garratt, I Polikarpov, AD Andricopulo, and QSAR Hologram. (2006). studies on farnesoid X receptor activators. Lett Drug Des Discov 3:261–267.
   Web of Science ®Google Scholar
• MS Castilho, RVC Guido, and AD Andricopulo. (2007). 2D Quantitative structure activity relationship studies on a series of cholesteryl ester transfer protein inhibitors. Bioorg Med Chem 15:6242–6252.
   PubMed Web of Science ®Google Scholar
• MS Castilho, RVC Guido, and AD Andricopulo. (2007). Classical and hologram QSAR studies on a series of tacrine derivatives as butyryleholinesterase inhibitors. Lett Drug Des Discov 4:106–113.
   Web of Science ®Google Scholar
• LG Ferreira, A Leitao, CA Montanari, and AD Andricopulo. (2007). Hologram quantitative structure-activity relationships for a class of inhibitors of HIV-1 protease. Lett Drug Des Discov 4:356–364.
   Web of Science ®Google Scholar
• DB Oliveira, and AC Gaudio. (2003). BuildQSAR: A new computer program for QSAR analysis. Quant Struct-Activ Relat 19:599–601.
   Google Scholar
• HQSARTM Manual. SYBYL 6.9.2, Tripos Inc., St. Louis, MO, 2003..
   Google Scholar
• KM Honorio, RC Garratt, I Polikarpov, AD Andricopulo, and QSAR 3D. (2007). comparative molecular field analysis on Nonsteroidal farsenoid X receptor activators. J Mol Graph Modell 25:921–927.
   PubMed Web of Science ®Google Scholar
• MS Castilho, MP Postigo, CB de Paula, CA Montanari, G Oliva, and AD Andricopulo. (2006). Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors. Bioorg Med Chem 14:516–527.
   PubMed Web of Science ®Google Scholar
• LD Salum, I Polikarpov, and AD Andricopulo. (2007). Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies. J Mol Graph Modell 25:434–442.
   Web of Science ®Google Scholar
• S Wold, E Johansson, and M Cocchi. PLS — Partial Least Square projections to latent structures. In: H Kubinyi. editor3D QSAR in Drug Design. Leiden: ESCOM; (1993). p 523–550.
   Google Scholar
• AM Doweyko. (2004). 3D-QSAR illusions. J Comput Aided Mol Des 18:587–596.
   PubMed Web of Science ®Google Scholar
• A Golbraikh, M Shen, Z Xiao, YD Xiao, KH Lee, and A Tropsha. (2003). Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17:241–253.
   PubMed Web of Science ®Google Scholar
• A Golbraikh, and A Tropsha. (2002). Beware of q²! J Mol Graph Model 20:269–276.
   PubMed Web of Science ®Google Scholar
• H Liu, and P Gramatica. (2007). QSAR study of selective ligands for the thyroid hormone receptor beta. Bioorg Med Chem 15:5251–5261.
   PubMed Web of Science ®Google Scholar